June 20, 2025

Orthofix Medical Inc. (OFIX) Investor Outlook: Assessing the 135.75% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX) is carving a niche in the healthcare sector, particularly in the medical devices industry. With its strategic focus on innovative solutions in spine and orthopedics,..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a Potential 244% Upside Despite Challenges

Tilray Brands, Inc. (NASDAQ: TLRY) has emerged as a notable player in the healthcare sector, focusing on specialty and generic drug manufacturing. Despite the challenges inherent in the cannabis industry,..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a 92% Potential Upside in the Biotech Arena

Oculis Holding AG (NASDAQ: OCS), a Swiss biopharmaceutical company, is capturing investor attention with its strong growth potential in the healthcare sector. Specializing in cutting-edge ophthalmic treatments, Oculis is making..

KalVista Pharmaceuticals, Inc. (KALV): Investor Outlook Reveals 114.82% Potential Upside in Biotechnology Sector

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and remarkable potential upside. Headquartered in Cambridge, Massachusetts, this clinical-stage..

Xencor, Inc. (XNCR) Stock Analysis: Unpacking the 237% Potential Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its significant 237% potential upside. Operating within the dynamic biotechnology sector, Xencor is at the forefront of..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 92.90% Upside Potential in the Healthcare Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector specializing in medical devices, has recently captured investor attention with a staggering potential upside of 92.90%. With a..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 60% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a company nestled within the dynamic biotechnology sector, presents an intriguing opportunity for investors with its significant potential upside. With a market capitalization of $531.01..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Compelling 85% Upside Potential in the Biotech Sector

Individual investors eyeing opportunities in the biotechnology sector may find Enliven Therapeutics, Inc. (NASDAQ: ELVN) an intriguing prospect. With a market capitalization of $1.27 billion, this clinical-stage biopharmaceutical company is..

Owens & Minor, Inc. (OMI) Stock Analysis: Unveiling a 27% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI) stands as a notable player in the healthcare sector, specifically within the medical distribution industry. Based in Glen Allen, Virginia, and with a rich..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech with 257% Potential Upside in the Fight Against IBD

Spyre Therapeutics, Inc. (SYRE) is capturing the attention of investors with its impressive potential upside of 257.43%, a figure that stands out in the volatile world of biotechnology investing. As..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating Challenges with Innovative Healthcare Solutions

Semler Scientific, Inc. (NASDAQ: SMLR), a healthcare-focused company based in Santa Clara, California, is making waves in the medical devices industry. With a market capitalization of $419.73 million, Semler is..

Cronos Group Inc. (CRON) Stock Analysis: Navigating Growth in a Dynamic Cannabis Market

Cronos Group Inc. (NASDAQ: CRON), a cannabinoid company based in Stayner, Canada, is making notable strides in the burgeoning cannabis sector. With a market capitalization of $736.15 million, Cronos stands..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges with a 9.74% Potential Upside

Enhabit, Inc. (NASDAQ: EHAB), a notable player in the healthcare sector, specifically within the medical care facilities industry, is carving out its niche in the United States by providing essential..

Neuropace, Inc. (NPCE) Stock Analysis: A Promising 61.56% Upside in the Medical Device Sector

Neuropace, Inc. (NPCE), a key player in the medical devices industry, is making waves with its innovative technologies aimed at treating drug-resistant focal epilepsy. Headquartered in Mountain View, California, Neuropace..

Praxis Precision Medicines, Inc. (PRAX) Stock Analysis: Uncovering a Staggering 127% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a beacon in the biotechnology sector, is capturing investor attention with its significant potential upside of 127.29%. Specializing in innovative therapies for central nervous..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a 270% Potential Upside in Biotechnology

REGENXBIO Inc. (NASDAQ: RGNX) is capturing the attention of investors with its promising position in the biotechnology sector, especially with a staggering potential upside of 270.48%. Let’s delve into the..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 243% Upside

For investors with an eye on the healthcare sector, Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling opportunity. Operating within the biotechnology industry, Vir Biotechnology is a clinical-stage biopharmaceutical company..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a Compelling 123.76% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company headquartered in Waltham, Massachusetts, is making waves in the healthcare sector with its focus on precision therapies for genetically defined diseases. With..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Navigating a Volatile Biotech Terrain with a 78% Revenue Growth

Sage Therapeutics, Inc. (NASDAQ: SAGE) is making waves in the biotechnology sector with a remarkable 78% revenue growth, drawing the attention of investors focused on companies with innovative approaches in..

Upstream Bio, Inc. (UPB) Stock Analysis: A Potential 366.79% Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB), a burgeoning name in the biotechnology sector, is generating significant buzz among investors due to its substantial potential upside. With a current market cap of..

Search

Funds

June 20, 2025

Search

Funds

June 20, 2025

FTSE 100

Funds